Pharmacogenomics Results Affect Patients' Plan of Care and Changes in Medication Prescription(s)

Pharmacogenomic Clinical Trial

Official title:

Medical Provider Experience and Assessment on Documenting Prescribing and Plan of Care Changes Due to Pharmacogenomics Testing

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT03322189
• Other study ID #: PAS1463
• Status: Enrolling by invitation
• Start date: March 22, 2017
• Est. completion date: April 1, 2020

Study information

• Verified date: January 2019
• Source: Data Collection Analysis Business Management
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Current providers' standard operating procedures on pharmacogenomic testing patients

Description:

The general design of this study is collecting data and reviewing Principal Investigators' Standard Operating Procedures on Pharmacogenomic testing and changes made to their specific SOP.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 200
• Est. completion date: April 1, 2020
• Est. primary completion date: March 22, 2020
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 64 Years

Eligibility

Inclusion Criteria:

• Must be a Medical Practitioner

• Medical Doctor (MD)

• Doctor of Osteopathic (DO)

• Physician Assistant (PA)

• Advanced Practice Registered Nurse (APRN)

• Nurse Practioner (NP)

• Must have a current standard operating procedure that includes obtaining/reviewing medical history.

Exclusion Criteria:

• Government-funded insurance data cannot be included in the study.

Related Conditions & MeSH terms

• Pharmacogenomic

Intervention

Genetic:
• pharmacogenomic
Standard Operating Procedures on Pharmacogenomic testing and changes made to specific SOP

Locations

Country	Name	City	State
United States	DCABM	Land O' Lakes	Florida

Sponsors (2)

Lead Sponsor	Collaborator
Data Collection Analysis Business Management	PAS Research Services

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Provider Structures and Processes	Plan of Care Changes due to Pharmacogenomic testing. Provider based observational survey system on the health and well-being of patients and populations	36 months